Request Appointment
10 E 102nd StNew York, NY 10029
Fax+1 212-423-0522
Overview of Dr. Marron
Dr. Thomas Marron is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai South Nassau, New York Eye and Ear Infirmary of Mount Sinai, and NYC Health + Hospitals / Elmhurst. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 14 years. He is one of 187 doctors at The Mount Sinai Hospital and one of 25 doctors at Mount Sinai South Nassau who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2014 - 2017- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2012 - 2014
- Icahn School of Medicine at Mount SinaiClass of 2012
Mount Sinai Graduate School of Biological SciencesPhD
Certifications & Licensure
NY State Medical License 2013 - 2026
NJ State Medical License 2022 - 2023
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) Start of enrollment: 2020 Mar 05
- Interferon Lambda Therapy for COVID-19 Start of enrollment: 2020 Sep 01
- Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma Start of enrollment: 2020 Aug 19
Publications & Presentations
PubMed
- Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.Pei-Chang Lee, Alessio Cortellini, Bernardo Stefanini, Changhoon Yoo, Hong Jae Chon
European Journal of Cancer. 2026-06-03 - Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score.Lorenzo Canova, Eleonora Alimenti, Lorenzo Argiento, Giuseppe Cabibbo, Francesco Tovoli
Clinical Gastroenterology and Hepatology. 2026-05-25 - A Dermatologist's Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0.Nicholas Gulati, Brandon R Block, Jaanvi Mehta, Thomas U Marron
JAMA Oncology. 2026-05-21
Press Mentions
Promising Vaccine May Prevent Certain Cancers from ReturningAugust 18th, 2025- Mount Sinai and Cancer Research Institute Team Up to Improve Patient Outcomes in ImmunotherapyJune 17th, 2025
- OCCAM Immune and Cancer Research Institute Join Forces to Advance ImmunotherapyJune 16th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
